Skip to main content
. 2021 Nov 29;9(12):1791. doi: 10.3390/biomedicines9121791

Table 1.

Demographical and clinical variables of the studied population at the beginning of data collection compared to patients at the 6-month follow-up, patients who had a stroke six months later, and patients 48 h after admission.

All Patients Recruited vs. Patients Available to Follow-Up at 6 Months. Comparison of All Patients Recruited Who Experienced a Cerebrovascular Event (CVA) by the 6 Month Follow-Up vs. Patients with No Post-COVID-19 CVA.
All (n = 105) 6 months (n = 51) No Stroke (n = 95) Stroke (n = 10)
Age [X ± SD] 62.4 ± 15.52 58.4 + 18.50 64.1 ± 15.07
Age Below 60 [%] 43.4 33.9 44.2 40.0
Over 60 [%] 56.6 66.1 55.8 60.0
Gender Male [%] 60.0 62.7 57.9 80.0
Female [%] 40.0 37.3 42.1 20.0
Height Meters [X ± SD] 1.71 ± 0.08 1.72 ± 0.10 1.70 ± 0.10 * 1.74 ± 0.12 *
Weight Kilograms [X ± SD] 93.1 ± 20.11 88.9 ± 24.44 93.4 ± 27.72 90.6 ± 21.85
Race Hispanic Latino [%] 27.6 8.5 26.3 40.0
Black [%] 62.9 61.0 64.2 50.0
Other/UNK/Asian [%] 9.5 30.5 9.5 10.0
Clinical characteristics All (n = 105) 6 months (n = 51) No Stroke (n = 95) Stroke (n = 10)
Mortality [%] 21.9 32.2 20.0 40.0
Length of Stay [days; X ± SD] 16.6 ± 14.18 # 38.0 ± 31.21 # 15.5 ± 22.88 17.4 ± 24.21
ICU [%] 50.0 71.2 49.5 63.6
Intubated [%] 33.0 50.8 33.7 30.0
ECMO [%] 9.4 15.3 7.4 30.0
APACHE + 1 h [X ± SD] 11.0 ± 6.26 12.6 ± 7.88 10.8 ± 8.01 14.1 ± 4.79
APACHE + 24 h [X ± SD] 11.0 ± 5.83 12.9 ± 7.05 10.5 ± 7.45 * 16.1 ± 2.69 *
MOF All (n = 105) No Stroke (n = 95) Stroke (n = 10)
Admission 48 h Admission 48 h Admission 48 h
MODS [X ± SD] 3.0 ± 2.72 3.2 ± 2.96 2.9 ± 2.71 3.3 ± 3.06 4.7 ± 2.31 ** 2.3 ± 1.64 **

* Statistical difference when comparing patients with stroke vs. patients without stroke. ** Statistical difference when comparing patients at admission vs. patients at 48 h from admission. # Statistical difference when comparing patients at admission vs. patients at 6 months from admission.